EUV Photoresist Pioneer Inpria Raises $31 Million in Series C Funding Led by JSR Corporation
Inpria, a pioneer in high-resolution metal oxide photoresists for extreme ultraviolet lithography (EUV), today announced that it has secured $31 million in Series C funding from a broad syndicate representing leaders from across the semiconductor manufacturing ecosystem. This financing was led by photoresist manufacturer and existing investor, JSR Corporation. New investors included SK hynix Inc. and TSMC Partners. The round also included participation from existing investors Air Liquide Venture Capital ALIAD, Applied Ventures, Intel Capital and Samsung Venture Investment Corporation.
“Inpria is the world leader in metal oxide photoresists for advanced EUV lithography process,” said Mark Slezak, President of JSR Micro and new Inpria Board Director. “We are excited to expand our partnership with Inpria as we collaborate with them on quality and overall market acceptance.”
Comprised of tin-oxide nanoclusters, Inpria photoresists deliver higher resolution with building blocks a fraction the size of traditional polymer-based resists which are tuned to optimally absorb EUV photons. With unparalleled etch selectivity, Inpria photoresists enable simpler manufacturing flows and larger process windows for an overall reduction in cost of ownership. Inpria recently brought online its high-volume manufacturing plant to support the initial production ramp for customers.
“We believe our investor participation serves as an indicator for Inpria’s strategic significance to the semiconductor industry. We are delighted that our investor base now includes all semiconductor manufacturers worldwide that are currently adopting EUV patterning. This achievement is complemented by the strong participation of photoresist, equipment and industrial chemical manufacturer investors as well,” added Andrew Grenville, CEO of Inpria. “We look forward to working with our global partners to deliver a breakthrough EUV photoresist platform to the industry.”
About Inpria
Inpria Corporation is the world leader in metal oxide photoresist design, development and manufacturing. Inpria’s EUV photoresists enable semiconductor manufacturers to realize the full potential of EUV lithography. Learn more at www.inpria.com.
About JSR Corporation
JSR Corporation is a multinational company employing more than 9,000 people worldwide and a leading materials supplier in a variety of technology driven markets. JSR’s global network is headquartered in Tokyo (Japan) and has factories and offices in Europe, USA, China, Taiwan, Korea, Singapore and Thailand. JSR is a research-oriented organization that pursues close collaborations with leading innovators in a number of industries that are a key to the present and future welfare of human society: life-sciences, energy storage, synthetic rubbers, electronic materials, display and edge computing related items. For more information about JSR Corporation, please go to www.jsr.co.jp.
About SK hynix Inc.
www.skhynix.com
About ALIAD
www.airliquide.com/connected-innovation/aliad-venture-capital
About Applied Ventures
www.appliedventures.com or follow @Applied_VC
About Intel Capital
www.intelcapital.com or follow @Intelcapital
About Samsung Venture Investment Corporation
www.samsungventure.co.kr
View source version on businesswire.com: https://www.businesswire.com/news/home/20200220005292/en/
Contact information
Ann Carney Nelson
541-844-2812
media-relations@inpria.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fishawack Health Adds Market Access and Commercial Strategy Consultancy Skysis as Part of Its Bold Growth Plans8.4.2020 22:15:00 EEST | Press release
Fishawack Health, the global healthcare communications agency, announces the acquisition of Skysis, a boutique consulting firm providing integrated market access and commercial strategy solutions based in the US. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200408005692/en/ The Skysis team (Photo: Business Wire) Skysis expertise bolsters Fishawack Health’s impressive consulting capabilities. The company brings with it the ability to connect interdependencies across healthcare professional (HCP), payer, channel, and patient stakeholders. It is the first acquisition with Fishawack Health’s new investor, Bridgepoint. Oliver Dennis, Fishawack Health co-founder and CEO, said: “In partnering with Bridgepoint, we have made a step-change in our ambition. We’re delighted today to add Skysis to the group. They bring strategy and market access across the entire commercial life cycle, making them an important addition to our strategic
The Estée Lauder Companies to Issue $700 Million of Senior Notes8.4.2020 19:11:00 EEST | Press release
The Estée Lauder Companies Inc. (NYSE:EL) today announced the offering and pricing of $700 million aggregate principal amount of its 2.600% Senior Notes due 2030. The offering was made pursuant to an effective registration statement filed by The Estée Lauder Companies Inc. with the Securities and Exchange Commission and effective as of May 21, 2018. The closing of the offering is expected to occur on or about April 13, 2020. The Company intends to use the net proceeds of the offering for general corporate purposes, which may include operating expenses, working capital, capital expenditures and redemption and repayment of short-term or long-term borrowings, including outstanding commercial paper as it matures. Pending any specific application, it may initially invest funds in short-term marketable securities. BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC, BNP Paribas Securities Corp. and MUFG Securities Americas Inc. are the joint book-running managers
Carbios Announces the Publication of an Article on Its Enzymatic Recycling Technology in the Prestigious Scientific Journal Nature8.4.2020 19:00:00 EEST | Press release
Regulatory News: CARBIOS (Euronext Growth Paris: ALCRB) (Paris:ALCRB), a company pioneering new bio-industrial solutions to reinvent the lifecycle of plastic and textile polymers, announces the publication of an article in the prestigious scientific journal Nature, entitled “ An engineered PET-depolymerase to break down and recycle plastic bottles”. The article is co-authored by scientists at Carbios and at the Company’s renowned academic partner, the Toulouse Biotechnology Institute 1 (TBI). The article describes the development of a novel enzyme, which can biologically depolymerize all polyethylene terephthalate (PET) plastic waste, followed by an extremely efficient recycling into new bottles. PET is the most common thermoplastic polymer and is used to manufacture bottles, polyester clothing fibers, food containers, and various thermoformed packaging and components. Carbios’ recycling process, the first of its kind, initiates a real transition to a circular economy and can better pr
HPC-AI Advisory Council and National Supercomputing Centre Singapore Expand 3rd APAC HPC-AI Competition to Address COVID-198.4.2020 15:30:00 EEST | Press release
The HPC-AI Advisory Council (HPCAIAC) and the National Supercomputing Centre (NSCC) Singapore announced today that they have joined the global fight against COVID-19 by expanding the 2020 APAC HPC-AI competition to address education and applied learning towards accelerating bioscience research and discovery. As part of the updated competition, student teams are now tasked to research, find and choose an HPC or AI application that can potentially be used as part of the global fight against COVID-19. Teams must demonstrate testing and benchmarking of the application, as well as explain how this application can best be accelerated. In addition, teams will also be required to focus on tuning and accelerating NAMD, a molecular dynamics code designed for high-performance simulation of large biomolecular systems. The NAMD application is being used at various supercomputing sites to run massive simulations of COVID-19 to aid researchers design new drugs and vaccines to combat the virus. The AP
XPRIZE Taps Visionary Sci-Fi Writers to Imagine the Future of Telepresence Technologies8.4.2020 15:00:00 EEST | Press release
XPRIZE , the global leader in incentivized prize competitions, in partnership with ANA, Japan’s 5-star airline, announce Avatars Inc, a unique online anthology that blends original science fiction stories with a writing competition to imagine novel use-cases of telepresence technology in the future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200408005209/en/ Avatars Inc (www.avatars.inc) is a free online sci-fi anthology presented as a collection of avatar ‘memories’ spanning the 21st century, including new stories by James SA Corey, Adrian Tchaikovsky, Tade Thompson, JY Yang, Ken Liu, Charles Yu, and more. (Illustration by Michelle Thompson, courtesy of XPRIZE.) The anthology, edited by Ann VanderMeer, includes 24 original pieces by high-profile authors including James SA Corey, Adrian Tchaikovsky, Tade Thompson, Pat Cadigan, JY Yang, Ken Liu, Charles Yu, Paul McAuley, K Chess, Johanna Sinisalo, and Aliette de Bodard. T
Seoul Viosys’ Violeds Technology, with Proven 99.9% Sterilization of New Coronavirus (COVID-19) in 30 Seconds, Now Adopted for Automotive Indoor Sterilization Solution8.4.2020 13:35:00 EEST | Press release
Seoul Viosys(KOSDAQ: 092190), the world’s first compound semiconductor for short wavelengths solutions, announced that Violeds, its clean sterilization technology, has been adopted by Yanfeng, a leading global automotive supplier. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200408005308/en/ Fig 1. Violeds technology adopted by Yanfeng (2019 consolidated revenue of USD 20 billion) for in-vehicle UV sanitizer (Graphic: Business Wire) The Yanfeng’s in-vehicle UV sanitizer, with Violeds technology, will safely detect for absence of occupants before activating lamps for a period of 10 minutes that can sterilize the cabin including cockpit, seating and steering wheel. The sterilization lamp is embedded in the ceiling for maximum coverage and allows for sterilization of the harmful bacteria and viruses inside. Seoul Viosys and SETi will also launch portable clean products for 99.9% sterilization of all kinds of viruses and bacte
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom